Published in Psychiatry Res on October 30, 2004
Meta-analysis of the symptom structure of obsessive-compulsive disorder. Am J Psychiatry (2008) 2.64
Further development of YBOCS dimensions in the OCD Collaborative Genetics study: symptoms vs. categories. Psychiatry Res (2008) 1.54
Taboo thoughts and doubt/checking: a refinement of the factor structure for obsessive-compulsive disorder symptoms. Psychiatry Res (2007) 1.36
Obsessive-compulsive disorder: an integrative genetic and neurobiological perspective. Nat Rev Neurosci (2014) 1.19
Culture and the anxiety disorders: recommendations for DSM-V. Depress Anxiety (2010) 1.18
Symptom dimensions in OCD: item-level factor analysis and heritability estimates. Behav Genet (2010) 1.10
Juvenile-onset OCD: clinical features in children, adolescents and adults. Acta Psychiatr Scand (2008) 0.88
Symptom dimensions are associated with age of onset and clinical course of obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry (2013) 0.82
Latent class analysis of the Yale-Brown Obsessive-Compulsive Scale symptoms in obsessive-compulsive disorder. Compr Psychiatry (2010) 0.77
Behavior therapy augments response of patients with obsessive-compulsive disorder responding to drug treatment. J Clin Psychiatry (2005) 1.80
Partitioning the heritability of Tourette syndrome and obsessive compulsive disorder reveals differences in genetic architecture. PLoS Genet (2013) 1.68
A double-blind switch study of paroxetine and venlafaxine in obsessive-compulsive disorder. J Clin Psychiatry (2004) 1.57
Dysfunctional reward circuitry in obsessive-compulsive disorder. Biol Psychiatry (2011) 1.37
A double blind comparison of venlafaxine and paroxetine in obsessive-compulsive disorder. J Clin Psychopharmacol (2003) 1.36
Autonomic and neuroendocrine responses to a psychosocial stressor in adults with autistic spectrum disorder. J Autism Dev Disord (2006) 1.26
Altered pain processing in veterans with posttraumatic stress disorder. Arch Gen Psychiatry (2007) 1.22
Thinner prefrontal cortex in veterans with posttraumatic stress disorder. Neuroimage (2008) 1.12
Low level of dopaminergic D2 receptor binding in obsessive-compulsive disorder. Biol Psychiatry (2004) 1.12
Wireless implantable micro-stimulation device for high frequency bilateral deep brain stimulation in freely moving mice. J Neurosci Methods (2012) 1.06
Glutamate and anxiety. Eur Neuropsychopharmacol (2004) 1.05
The role of dopamine in obsessive-compulsive disorder: preclinical and clinical evidence. J Clin Psychiatry (2004) 1.04
Neural correlates of associative learning and memory in veterans with posttraumatic stress disorder. J Psychiatr Res (2007) 1.04
A double-blind, randomized, placebo-controlled trial of quetiapine addition in patients with obsessive-compulsive disorder refractory to serotonin reuptake inhibitors. J Clin Psychiatry (2004) 1.03
Social anxiety disorder and generalized anxiety disorder: serotonergic and dopaminergic neurocircuitry. J Clin Psychiatry (2002) 1.02
Pharmacotherapy for disordered sleep in post-traumatic stress disorder: a systematic review. Int Clin Psychopharmacol (2006) 0.98
Deep brain stimulation reveals a dissociation of consummatory and motivated behaviour in the medial and lateral nucleus accumbens shell of the rat. PLoS One (2012) 0.94
Symptom dimensions in obsessive-compulsive disorder: factor analysis on a clinician-rated scale and a self-report measure. Psychopathology (2004) 0.93
Clinical relevance of comorbidity in anxiety disorders: a report from the Netherlands Study of Depression and Anxiety (NESDA). J Affect Disord (2012) 0.92
Sympathetic activity and hypothalamo-pituitary-adrenal axis activity during sleep in post-traumatic stress disorder: a study assessing polysomnography with simultaneous blood sampling. Psychoneuroendocrinology (2012) 0.92
Effect of a pharmacological intervention on quality of life in patients with obsessive-compulsive disorder. Int Clin Psychopharmacol (2003) 0.92
Permanent deficits in serotonergic functioning of olfactory bulbectomized rats: an in vivo microdialysis study. Biol Psychiatry (2005) 0.91
Spatial working memory deficits in obsessive compulsive disorder are associated with excessive engagement of the medial frontal cortex. Neuroimage (2003) 0.90
Cross-disorder genome-wide analyses suggest a complex genetic relationship between Tourette's syndrome and OCD. Am J Psychiatry (2014) 0.90
Precuneal activity during encoding in veterans with posttraumatic stress disorder. Prog Brain Res (2008) 0.90
A score for predicting response to pharmacotherapy in obsessive-compulsive disorder. Int Clin Psychopharmacol (2003) 0.89
Prediction of response to paroxetine and venlafaxine by serotonin-related genes in obsessive-compulsive disorder in a randomized, double-blind trial. J Clin Psychiatry (2007) 0.88
Effects of dietary tryptophan variations on extracellular serotonin in the dorsal hippocampus of rats. Psychopharmacology (Berl) (2003) 0.88
Female hormones affect symptom severity in obsessive-compulsive disorder. Int Clin Psychopharmacol (2006) 0.87
Reduced sensitivity in the recognition of anger and disgust in social anxiety disorder. Cogn Neuropsychiatry (2006) 0.87
Assessment of DSM-IV personality disorders in obsessive-compulsive disorder: comparison of clinical diagnosis, self-report questionnaire, and semi-structured interview. J Pers Disord (2003) 0.87
Long-term behavioral changes after cessation of chronic antidepressant treatment in olfactory bulbectomized rats. Biol Psychiatry (2006) 0.87
Sensory gating and sensorimotor gating in medication-free obsessive-compulsive disorder patients. Int Clin Psychopharmacol (2010) 0.87
Axis I and II comorbidity in a large sample of patients with obsessive-compulsive disorder. J Affect Disord (2004) 0.87
Decreased thalamic blood flow in obsessive-compulsive disorder patients responding to fluvoxamine. Psychiatry Res (2005) 0.87
Attention and cognition in patients with obsessive-compulsive disorder. Psychiatry Clin Neurosci (2007) 0.86
Impaired neuroendocrine and immune response to acute stress in medication-naive patients with a first episode of psychosis. Schizophr Bull (2010) 0.85
Polymorphisms of the LEP- and LEPR gene and obesity in patients using antipsychotic medication. J Clin Psychopharmacol (2009) 0.84
Emerging skin-picking behaviour after serotonin reuptake inhibitor-treatment in patients with obsessive-compulsive disorder: possible mechanisms and implications for clinical care. J Psychopharmacol (2003) 0.84
Spatial working memory in obsessive-compulsive disorder improves with clinical response: A functional MRI study. Eur Neuropsychopharmacol (2006) 0.82
Sexual pleasure in women with obsessive-compulsive disorder? J Affect Disord (2006) 0.82
Obstructive sleep apnea in combat-related posttraumatic stress disorder: a controlled polysomnography study. Eur J Psychotraumatol (2011) 0.81
Quetiapine augments the effect of citalopram in non-refractory obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled study of 76 patients. J Clin Psychiatry (2009) 0.81
Electroconvulsive therapy has acute immunological and neuroendocrine effects in patients with major depressive disorder. J Affect Disord (2010) 0.81
Extracellular serotonin in the prefrontal cortex is limited through terminal 5-HT(1B) autoreceptors: a microdialysis study in knockout mice. Psychopharmacology (Berl) (2002) 0.81
Behavioral pattern analysis and dopamine release in quinpirole-induced repetitive behavior in rats. J Psychopharmacol (2010) 0.80
Role of 5-HT1B receptors in the regulation of extracellular serotonin and dopamine in the dorsal striatum of mice. Eur J Pharmacol (2003) 0.80
Association between serotonergic candidate genes and specific phenotypes of obsessive compulsive disorder. J Affect Disord (2006) 0.80
Fluvoxamine CR in the long-term treatment of social anxiety disorder: the 12- to 24-week extension phase of a multicentre, randomized, placebo-controlled trial. Int J Neuropsychopharmacol (2003) 0.80
Neuroendocrine and immune responses to a cognitive stress challenge in veterans with and without PTSD. Eur J Psychotraumatol (2012) 0.80
Combined HTR2C-LEP genotype as a determinant of obesity in patients using antipsychotic medication. J Clin Psychopharmacol (2010) 0.80
Predictors of pharmacotherapy response in anxiety disorders. Curr Psychiatry Rep (2005) 0.80
Mirtazapine in generalized social anxiety disorder: a randomized, double-blind, placebo-controlled study. Int Clin Psychopharmacol (2010) 0.79
The effects of selective serotonin reuptake inhibitors on extracellular 5-HT levels in the hippocampus of 5-HT(1B) receptor knockout mice. Eur J Pharmacol (2002) 0.79
Efficacy of quetiapine in generalized social anxiety disorder: results from an open-label study. J Clin Psychiatry (2005) 0.79
Signaling pathways involved in Ca2+- and Pb2+-induced vesicular catecholamine release from rat PC12 cells. Brain Res (2002) 0.79
Compulsivity in mouse strains homologous with chromosomes 7p and 15q linked to obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet (2010) 0.79
Neuropsychological performance is related to current social and occupational functioning in veterans with posttraumatic stress disorder. Depress Anxiety (2009) 0.79
Role of extracellular serotonin levels in the effect of 5-HT1B receptor blockade. Psychopharmacology (Berl) (2003) 0.78
Metabotropic glutamate II receptor agonists in panic disorder: a double blind clinical trial with LY354740. Int Clin Psychopharmacol (2005) 0.78
Hypersensitivity of 5-HT2 receptors in OCD patients. An increased prolactin response after a challenge with meta-chlorophenylpiperazine and pre-treatment with ritanserin and placebo. J Psychiatr Res (2008) 0.78
Disgust affects TNF-alpha, IL-6 and noradrenalin levels in patients with obsessive-compulsive disorder. Psychoneuroendocrinology (2009) 0.78
Polymorphisms of the LEP, LEPR and HTR2C gene: obesity and BMI change in patients using antipsychotic medication in a naturalistic setting. Pharmacogenomics (2011) 0.78
Neonatal basolateral amygdala lesions affect monoamine and cannabinoid brain systems in adult rats. Int J Neuropsychopharmacol (2006) 0.78
Bupropion for patients with obsessive-compulsive disorder: an open-label, fixed-dose study. J Clin Psychiatry (2005) 0.77
The influence of amphetamine on language activation: an fMRI study. Psychopharmacology (Berl) (2005) 0.77
An evaluation of the effect of NAS-181, a new selective 5-HT(1B) receptor antagonist, on extracellular 5-HT levels in rat frontal cortex. Naunyn Schmiedebergs Arch Pharmacol (2003) 0.77
Synergistic dopamine increase in the rat prefrontal cortex with the combination of quetiapine and fluvoxamine. Psychopharmacology (Berl) (2004) 0.77
Response to serotonin reuptake inhibitors in OCD is not influenced by common CYP2D6 polymorphisms. Int J Psychiatry Clin Pract (2009) 0.76
Marked inbred mouse strain difference in the expression of quinpirole induced compulsive like behavior based on behavioral pattern analysis. Eur Neuropsychopharmacol (2012) 0.76
Haloperidol counteracts the ketamine-induced disruption of processing negativity, but not that of the P300 amplitude. Int J Neuropsychopharmacol (2009) 0.76
Behavioural effects of rapid intravenous administration of meta-chlorophenylpiperazine in patients with panic disorder and controls. Eur Neuropsychopharmacol (2004) 0.76
Effects of paroxetine and venlafaxine on immune parameters in patients with obsessive compulsive disorder. Psychoneuroendocrinology (2005) 0.76
The Netherlands Obsessive Compulsive Disorder Association (NOCDA) study: design and rationale of a longitudinal naturalistic study of the course of OCD and clinical characteristics of the sample at baseline. Int J Methods Psychiatr Res (2012) 0.76
Serotonergic functioning in children with oppositional defiant disorder: a sumatriptan challenge study. Biol Psychiatry (2002) 0.75
Catechol-O-methyltranferase gene expression is associated with response to citalopram in obsessive-compulsive disorder. Int J Psychiatry Clin Pract (2012) 0.75
Paroxetine augmentation in patients with generalised social anxiety disorder, non-responsive to mirtazapine or placebo. Hum Psychopharmacol (2011) 0.75
Effects of quetiapine on cognitive functioning in obsessive-compulsive disorder. Int Clin Psychopharmacol (2007) 0.75
Effect of olanzapine on glutamate levels in cerebrospinal fluid of patients with schizophrenia. J Clin Psychopharmacol (2002) 0.75
The association between CYP2D6 genotype and switching antipsychotic medication to clozapine. Eur J Clin Pharmacol (2013) 0.75